Skip to main content

Table 3 Multivariable Cox’s proportional hazard regression model to predict overall survival in the subgroup (10 LNs as Pentafecta threshold)

From: External validation of Pentafecta in patients undergoing laparoscopic radical cystectomy: results from a high-volume center

Variable

HR (95% CI)

P value

Sex (male vs. female)

0.72 (0.38–1.38)

0.325

Age (≤ 65 vs. > 65)

1.07 (0.63–1.81)

0.817

Diversion type (conduit vs. cutaneous ureterostomy)

1.31 (0.80–2.16)

0.289

Diversion type (neobladder vs. cutaneous ureterostomy)

0.79 (0.36–1.84)

0.476

Pathological T-stage (MIBC vs. NMIBC)

4.96 (2.61–9.40)

< 0.001

Pathological N-stage (N + vs. N−)

2.86 (1.31–6.22)

0.008

Smoking history (yes vs. no)

0.92 (0.55–1.55)

0.756

Neoadjuvant chemotherapy (yes vs. no)

0.92 (0.32–2.61)

0.870

Pentafecta (10 LNs) (yes vs. no)

0.31 (0.11–0.89)

0.029